Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
SuviCa is focused on the discovery and development of small molecules for the treatment of cancer. Currently, SuviCa has two small molecule protein synthesis inhibitors in pre-clinical development. SVC112 – With a patent filed for Composition of Ma...Show all
Company (Alive / Active)
Phone: 303-921-6680
PO Box 3131
Boulder, 80307
Colorado, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Bouvardin derivatives and therapeutic uses thereof | Aug 10, 2016 | Apr 16, 2019 | Patent |
Bourvadin derivatives and therapeutic uses thereof | Feb 21, 2013 | Sep 27, 2016 | Patent |